Menu
Recruiting NCT07312786

Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors

No phase Interventional Breast Cancer Survivor Colorectal Cancer Survivors

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: virtual self-management intervention.
Who it may be relevant to
Registry conditions: Breast Cancer Survivor, Colorectal Cancer Survivors. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors After Completing Primary Treatment

Overview

The goal of this study is to determine the feasibility of implementing a mobile health application for breast and colorectal cancer survivors following primary treatment. Developed in collaboration with Seamless MD, the intervention acts as an information hub, providing users with timely and evidence-based information related to follow-up care as well as health system/community-based resources and programs to meet their needs during this period of care. The goal of the intervention is to encourage open communication regarding survivorship expectations and provide survivors with appropriate information and support to meet their needs. This study will: 1. Test the feasibility of implementing the virtual intervention at two cancer centres in Atlantic Canada (Nova Scotia and New Brunswick) 2. Gather feedback regarding the intervention from cancer survivors and healthcare providers. Participants will have access to the intervention for a period of six months. Questionnaires will be distributed to participants through the intervention at baseline, 90 days, and 180 days to assess user experience. Semi-structured interviews will be conducted with select survivor participants and healthcare providers (oncology and primary care) to determine the feasibility and acceptability of this intervention.

Interventions

  • Behavioral virtual self-management intervention
    The intervention is a supportive information and self-management tool housed on the SeamlessMD mobile app, created in collaboration with the SeamlessMD development program and informed by foundational research. The application will be used as an information hub and self-management/navigation tool alongside usual care, to address the physical, psychosocial, and practical needs of breast and colorectal cancer survivors. Note that the intervention will not seek to change or impact a survivor's foll

Primary outcome measures

  • Recruitment [Time frame: During enrollment]
  • Retention [Time frame: Enrollment to day 180]
  • Usage of the Intervention [Time frame: Baseline to day 180]
  • Survivor and Provider Acceptability and Experience [Time frame: Interviews with survivor participants will be conducted after having access to the intervention for 180 days.]
Secondary outcome measures (3)
  • Fear of Recurrence [Time frame: Outcomes will be captured at baseline (study entry), on days 90 and 180, directly through the Seamless MD app software.]
  • Patient Activation [Time frame: Outcomes will be captured at baseline (study entry), on days 90 and 180, directly through the Seamless MD app software.]
  • Information Provision [Time frame: Outcomes will be captured at baseline (study entry), on days 90 and 180, directly through the Seamless MD app software.]

Eligibility criteria

Inclusion criteria

  • Adults older than 18 years, capable of providing informed consent
  • Diagnosed with stage I-III breast or colorectal cancer, and have completed primary treatment for their cancer (surgery and/or adjuvant systemic or radiation therapy) 6 months - 5 years ago

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Supportive care

Study locations

Canada · 2 centers
  • Saint John Regional Hospital — Saint John
  • Centre for Clinical Research QEII Health Sciences Centre — Halifax

Identifiers

NCT: NCT07312786 · 707168

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗